Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 87Carcinoma, Non-Small-Cell Lung 78Multiple Myeloma 72Prostatic Neoplasms 66Neoplasms 47Lymphoma 43Leukemia, Myeloid, Acute 42Melanoma 38Neoplasm Metastasis 37Lymphoma, Non-Hodgkin 33Ovarian Neoplasms 32Lung Neoplasms 32Squamous Cell Carcinoma of Head and Neck 31Hematologic Neoplasms 29Leukemia, Lymphocytic, Chronic, B-Cell 28Colorectal Neoplasms 26Triple Negative Breast Neoplasms 23Hodgkin Disease 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Myelodysplastic Syndromes 21Sarcoma 20Fallopian Tube Neoplasms 20Pancreatic Neoplasms 19Carcinoma, Renal Cell 19Lymphoma, Follicular 17Leukemia 17Head and Neck Neoplasms 17Glioma 17Urinary Bladder Neoplasms 16Recurrence 16

Interventions

Letrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Breast Cancer Female × 90 days × Clear all
NCT03747042 2026-03-16

Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer

University of Texas Southwestern Medical Center

Phase 2 Completed
61 enrolled 5 charts
Breast

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon âš¡